Transaction in Own Shares

Summary by AI ^BETAClose X

Essentra plc has purchased a total of 73,000 ordinary shares as part of its ongoing buyback programme. On April 7th, 11,500 shares were bought on the London Stock Exchange at an average price of 93.30 GBp. On April 9th, another 11,500 shares were acquired on the London Stock Exchange at an average price of 92.30 GBp. On April 13th, 50,000 shares were purchased on the London Stock Exchange with an aggregated average price of 85.1920 GBp. These shares are intended for cancellation, which will reduce the total number of issued ordinary shares to 284,689,244, impacting the total voting rights.

Disclaimer*

Essentra plc

15 April 2026

ESSENTRA PLC

Transaction in Own Shares

Essentra plc ("Essentra", or the "Company") announces that on 7, 9, and 13 April 2026 it purchased in 73,000 ordinary shares of 25 pence each in the Company ("Ordinary Shares") from Peel Hunt LLP as part of the buyback programme announced on 29 March 2023 (the "Buyback Programme").

Date	Trading Venue	Volume-weighted average price paid per share (GBp)	Aggregated number of shares purchased	Lowest price paid per share (GBp):	Highest price paid per share (GBp):
07/04/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	93.3000	11,500	93.3000	93.3000
09/04/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	92.300	11,500	92.300	92.300
13/04/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	85.1920	50,000	85.1000	85.1920

Essentra intends to cancel the purchased Ordinary Shares.

Following the settlement of the above purchases and cancellation, Essentra will have 284,689,244 Ordinary Shares of 25 pence each in issue (excluding 3,077,057 Ordinary Shares of 25 pence each held in treasury).

Upon cancellation, the figure 284,689,244 will represent the total number of voting rights in Essentra and can be used by shareholders once the shares have been cancelled as the denominator for the calculations by which they can determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Peel Hunt LLP as part of the Buyback Programme.

This announcement is made in accordance with the requirements of Listing Rule 12.4.6.

For further enquiries, please contact:

Essentra plc

Tim George, Deputy Company Secretary

Tel: +44 (0)1908 359100

Schedule of Purchases - Individual Transactions

Number of shares purchased	Transaction price (Gbp)	Market / Sytematic Internaliser	Date	Time of transaction	Trade ID
11500	92.3	XLON	07/04/2026	11:11:06	00191184205TRLO0
11500	92.3	XLON	09/04/2026	12:34:15	00192074684TRLO0
11500	85.5	XLON	13/04/2026	09:45:55	00192194010TRLO0
38500	85.1	XLON	13/04/2026	13:15:45	00192210753TRLO0

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END